Shauntell Solomon, DO
MOHS-Micrographic Surgery · Sarasota, FLNPI 1376779710
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $864 of the $977 with a category attached, or 88.4%. It is spread thinly across 20 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $299 and has fallen 93.2% since, to $20 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.
Across 46 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$178
- Novartis$106
- Genentech USA, Inc.$99
- Kerecis Limited$83
- AbbVie$69
- Organogenesis Inc.$63
- plus $379 from 14 others
What the payments were for
- Food & beverage$86488%
- Education$11312%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 6 | $178 |
| Novartis | 5 | $106 |
| Genentech USA, Inc. | 1 | $99 |
| Kerecis Limited | 6 | $83 |
| AbbVie | 3 | $69 |
| Organogenesis Inc. | 3 | $63 |
| Merz North America, Inc. | 2 | $55 |
| DUSA Pharmaceuticals, Inc. | 3 | $54 |
| Johnson & Johnson | 4 | $53 |
| Biofrontera Inc. | 2 | $32 |
| Incyte Corporation | 2 | $25 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Aclaris Therapeutics, Inc. | 1 | $24 |
| Pfizer | 1 | $20 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $16 |
| Dermavant Sciences, Inc. | 1 | $14 |
| Sanofi | 1 | $13 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
How this compares
$977 in reported general payments places this provider in the 35th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $528 |
| Triamcinolone Acetonide | 12 | $177 |
| Ketoconazole | 14 | $154 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Sarasota
- Nadia UratoSarasota$6K
- Shahjahan ShareefSarasota$3K
- Catherine MotoskoSarasota$3K
- Peter MatteiSarasota$2K
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.